Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MediBic To Start Providing Private DNA Bank Services In Japan

This article was originally published in PharmAsia News

Executive Summary

In May, MediBic, a Tokyo-based biotechnology company specializing in pharmacogenomics, will start providing private DNA bank services, a personalized medical treatment advisory service targeting individuals. MediBic has been providing genetic information and projections on drug efficacy and side effects to major pharmaceutical companies. The DNA private bank is a service that will identify an individual's predisposition and health risks based on personal DNA and provide customers with medical treatment advice on an ongoing basis. Analysis of personal DNA could identify health risks and project future health developments such as illness, allowing more effective prevention and management, the company says. Initially targeting affluent customers, MediBic eventually plans to popularize the service by lowering the cost. (Click here for more-Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068167

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel